& Eli Lilly antibody therapy has been granted emergency use authorization by US drug organizations to treat Covid-19, expanding access to treatment that early data indicates is effective in keeping people with coronavirus out of hospital
On Monday, organizers allowed the emergency use of the first experimental anti-COVID-19 antibody drug in patients who have not been admitted to hospital but are at risk of developing serious illness due to their age or other conditions.
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.